OverviewChartNewsTraderScreen

BVT Put 180 AMD 21.06.2024/  DE000VD09DD4  /

Stuttgart
2024-06-10  9:47:54 AM Chg.+0.26 Bid5:58:42 PM Ask5:58:42 PM Underlying Strike price Expiration date Option type
1.55EUR +20.16% 1.71
Bid Size: 69,000		 -
Ask Size: -		 ADVANCED MIC.DEV. D... 180.00 - 2024-06-21 Put
GlobeNewswire 3:15 PM AMD to Present at the UBS Women in Tech Summit
GlobeNewswire 1:00 PM SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire 06-08 4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire 06-06 AMD to Present at the Nasdaq London Investor Conference
GlobeNewswire 06-05 Ocular Therapeutix® to Host Investor Day on June 13, 2024
GlobeNewswire 06-05 YieldMax™ ETFs Announces Monthly Distributions on MSTY (106.33%), NVDY (101.82%), CONY (84.85%), YBI...
GlobeNewswire 06-05 Micron Samples Next-Gen Graphics Memory for Gaming and AI
GlobeNewswire 06-04 Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 06-03 Coherent Appoints Jim Anderson as Chief Executive Officer
GlobeNewswire 06-03 Opthea To Present at Clinical Trials at the Summit Meeting
GlobeNewswire 06-03 AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
GlobeNewswire 06-03 AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Road...
GlobeNewswire 06-03 AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire 05-29 GRANITESHARES SURPASSES $5B AUM AS TRADING VOLUMES SURGE
GlobeNewswire 05-29 Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer
GlobeNewswire 05-28 AMD Chair and Chief Executive Officer Dr. Lisa Su to Deliver the Opening Keynote at Computex 2024
GlobeNewswire 05-28 Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...
GlobeNewswire 05-28 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire 05-21 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire 05-21 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire 05-21 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire 05-21 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
TeleTrader 05-20 Microsoft will 'soon welcome' AMD, Intel chips
GlobeNewswire 05-20 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp 05-16 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization